Table 1. Approved Therapies for Autoimmune Disease and Their Targets Autoimmune diseases represent a wide range of disorders affecting specific organs or the entire body, all characterised by the ...

Biotechnology and life sciences companies Nuclera and Cytiva are combining technologies to accelerate the characterisation of proteins in drug development. The collaboration will merge Nuclera’s ...

Biotechnology company Amsbio has added antibodies to its range for stem cell research and the therapeutic field. “Not only can our antibodies help ensure your culture purity, but they also provide ...

Sequencing specialist PacBio has collaborated with Chulalongkorn University, implementing its PacBio HiFi whole genome sequencing (WGS) in the university’s Newport screening research programme. The ...

CRISPR screening is a powerful high-throughput strategy that utilises the programmability and accuracy of CRISPR-Cas systems like CRISPRko, CRISPRa, and CRISPRi to investigate gene function ...

French biotechnology and AI specialist company Owkin has launched the K Navigator, an agentic biomedical research co-pilot that can help to accelerate biomedical research. “The ultimate aim for K is ...

Laboratory instrument manufacturer Agilent Technologies has released the high-performance 24-well Seahorse XF Flex Analyser, designed to expand real-time metabolic analysis into optimised 3D tissue ...

CDMO Hovione and biotechnology company Firstgene Life Sciences (of Xlife Sciences) have collaborated to advance Hovione’s drug delivery platform for the targeted treatment of Hepatocellular Carcinoma ...

Biotechnology company InVitria has launched a chemically defined recombinant IL-2 for immune cell manufacturing called OptiLeukin 2. “With the introduction of OptiLeukin 2, we are providing a clean, ...

The Pharma AI Council (PAC), an organisation of pharma, biotech and medical device experts, has been launched to shape the innovation and use of generative and agentic AI solutions in these fields.

Biotechnology company Creative Biogene has recently launched a line of gamma-retroviral products capable of efficiently delivering genes into various cell types. Our gamma-retroviral products are ...

The European Commission has granted the amyloid-beta monoclonal antibody Leqembi Marketing Authorisation in the European Union. The medication was developed by pharmaceutical company Eisai and ...